BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//WA Innovation Calendar - ECPv6.17.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:WA Innovation Calendar
X-ORIGINAL-URL:https://wainnovationcalendar.com.au
X-WR-CALDESC:Events for WA Innovation Calendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Perth
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:AWST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Perth:20261029T140000
DTEND;TZID=Australia/Perth:20261029T160000
DTSTAMP:20260910T120509Z
CREATED:20260910T120337Z
LAST-MODIFIED:20260910T120509Z
UID:10008193-1793282400-1793289600@wainnovationcalendar.com.au
SUMMARY:From Bench to Breakthrough - Commercialisation Lessons from Biotech’s Front Lines
DESCRIPTION:What really happens on the path from research bench to commercialisation?\nTo launch the WA Therapeutics Accelerator\, HTG are bringing together industry leaders\, experienced founders and investors for an honest\, practical discussion about what it takes to translate therapeutic research into a successful commercial venture.\nBench to Breakthrough: Commercialisation Lessons from Biotech’s Front Lines explores the decisions that can make – or break – a promising biotech opportunity. Drawing on real therapeutic development journeys\, speakers will examine common pitfalls across: \n\nClinical development planning and evidence generation\nProduct–market fit and commercial positioning\nRegulatory strategy and manufacturing readiness\nFunding\, partnering and investor engagement\nBuilding the right team\, governance and execution capability\n\nThe session will feature four concise case studies\, followed by a panel discussion\, audience Q&A and networking. \nDesigned for researchers\, clinician-innovators\, startup founders\, investors\, technology-transfer professionals and industry partners\, this event will help participants make better-informed decisions earlier\, learn from challenges others have encountered\, and contribute to a stronger biotechnology ecosystem in Western Australia. \nSpeakers include:  \n\nDavid Fuller – Life Sciences Industry Veteran\, globally experienced CMO\, Dimerix\, Genzyme.\nLiddy McCall – Health Translation Group\, Argenica\, Dimerix\, iCeutica\, Macquarie Bank\nRichard Hopkins – Rex Ortho\, Cytophenix and Blinklabs\, previously Zelira\, Phylogica.\nMeg Thomas – Atherid Therapeutics CEO. Previous Clinical\, Ops and Regulatory roles including Argenica and Zelira.\n\nDate: Thursday 29 October 2026 \nTime: 2:00 pm–4:00 pm \nLocation: Harry Perkins Institute of Medical Research – McCusker Auditorium \nAbout WATA: The WA Therapeutics Accelerator is supported by HTG and the WA Government’s Innovation Pathways Program from the New Industries and Innovation Fund\, delivers strategic guidance to WA-based therapeutic researchers to accelerate their projects from the lab to investment readiness. Over 12 months\, the accelerator will select a small cohort of high-potential research projects for hands-on mentoring and support. There is potential for investment support for teams that are ready to advance their projects to the next phase of commercialisation.
URL:https://wainnovationcalendar.com.au/event/from-bench-to-breakthrough-commercialisation-lessons-from-biotechs-front-lines/
LOCATION:Harry Perkins Institute of Medical Research\, 6 Verdun Street\, Nedlands\, WA\, 6000\, Australia
CATEGORIES:Information Session / Launch,Seminar / Panel Discussion / Conversation,Workshop / Masterclass
ATTACH;FMTTYPE=image/png:https://wainnovationcalendar.com.au/wp-content/uploads/2026/09/Screenshot-2026-09-10-20.02.42.png
END:VEVENT
END:VCALENDAR